S&P 500
(0.37%) 5 118.98 points
Dow Jones
(0.29%) 38 350 points
Nasdaq
(0.40%) 15 991 points
Oil
(-0.52%) $83.41
Gas
(2.96%) $1.980
Gold
(0.02%) $2 347.70
Silver
(-0.01%) $27.53
Platinum
(3.16%) $951.25
USD/EUR
(-0.07%) $0.934
USD/NOK
(-0.10%) $11.01
USD/GBP
(-0.33%) $0.798
USD/RUB
(1.74%) $93.48

实时更新: Alkermes Plc [ALKS]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
60.98%
return -8.44%
SELL
34.15%
return -6.21%
最后更新时间29 Apr 2024 @ 22:21

1.17% $ 24.97

出售 27075 min ago

@ $26.12

发出时间: 11 Apr 2024 @ 03:05


回报率: -4.40%


上一信号: Apr 10 - 01:08


上一信号: 购买


回报率: -2.68 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:21):

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally...

Stats
今日成交量 77 249.00
平均成交量 2.01M
市值 4.17B
EPS $0 ( 2024-04-24 )
下一个收益日期 ( $0 ) 2024-07-22
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 8.16
ATR14 $0.0490 (0.20%)
Insider Trading
Date Person Action Amount type
2024-04-11 Lurker Nancy Buy 22 103 Non Qualified Stock Option (Right to Buy)
2024-04-11 Lurker Nancy Buy 11 255 Restricted Stock Unit Award
2024-04-11 Lurker Nancy Buy 4 833 Non Qualified Stock Option (Right to Buy)
2024-04-11 Lurker Nancy Buy 2 323 Restricted Stock Unit Award
2024-03-18 Nichols Christian Todd Sell 10 417 Ordinary Shares
INSIDER POWER
75.16
Last 99 transactions
Buy: 1 207 179 | Sell: 170 568

音量 相关性

長: -0.21 (neutral)
短: -0.20 (neutral)
Signal:(56.378) Neutral

Alkermes Plc 相关性

10 最正相关
BLPH0.935
ETNB0.93
RCM0.928
XGN0.926
RNEM0.923
GMVD0.922
DBVT0.917
NUZE0.916
CGEN0.915
NVCT0.912
10 最负相关
QADB-0.914
WNEB-0.905
EBACU-0.899
MPRA-0.898
PKOH-0.898
DRNA-0.898
JNCE-0.895
MLAI-0.892
SQQQ-0.892
VS-0.886

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Alkermes Plc 相关性 - 货币/商品

The country flag -0.35
( neutral )
The country flag -0.34
( neutral )
The country flag 0.00
( neutral )
The country flag 0.15
( neutral )
The country flag 0.51
( weak )
The country flag 0.04
( neutral )

Alkermes Plc 财务报表

Annual 2023
营收: $1.66B
毛利润: $1.37B (82.64 %)
EPS: $2.14
FY 2023
营收: $1.66B
毛利润: $1.37B (82.64 %)
EPS: $2.14
FY 2022
营收: $1.11B
毛利润: $893.69M (80.38 %)
EPS: $-0.970
FY 2021
营收: $1.17B
毛利润: $569.84M (48.55 %)
EPS: $-0.300

Financial Reports:

No articles found.

Alkermes Plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。